{
    "clinical_study": {
        "@rank": "51989", 
        "arm_group": {
            "arm_group_label": "Myelodysplastic syndrome patients", 
            "description": "Patients affected by myelodysplastic syndrome enrolled in the observational study"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to observe the number of new cases of infections per population\n      in a given time period and their characteristics in a pathology (myelodysplastic syndrome,\n      MDS)that involves ineffective production (or dysplasia) of a class of blood cells."
        }, 
        "brief_title": "Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients", 
        "completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Myelodysplastic Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Myelodysplastic Syndromes", 
                "Preleukemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "The scarcity and the inadequacy of data make impossible the writing of evidence-based\n      recommendations for prevention and management of infections in myelodysplastic syndrome.\n\n      The aim of this study is to evaluate the incidence and the spectrum of the infections of MDS\n      patients. Will be also evaluated potential risk factors.\n\n      This study could help the definition of the optimal management of MDS patients in terms of\n      prophylaxis of the infective complications and in terms of the correct administration of\n      growth factors."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All adult patients (>18 years) with newly diagnosed myelodysplastic syndrome or\n             patients who have undergone a bone marrow reevaluation;\n\n          -  Signed written informed consent;\n\n        Exclusion Criteria:\n\n          -  Psychiatric patients;\n\n          -  Patients with life expectancy less than three months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult myelodysplastic syndrome patients"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01951430", 
            "org_study_id": "MDS0413"
        }, 
        "intervention": {
            "arm_group_label": "Myelodysplastic syndrome patients", 
            "intervention_name": "Antibiotic and antifungal drugs", 
            "intervention_type": "Drug", 
            "other_name": [
                "levofloxacine;", 
                "cyprofloxacine;", 
                "co-trimoxazole;", 
                "chinolones;", 
                "cephalosporins;", 
                "penicillines;", 
                "other betalactams;", 
                "macrolids;", 
                "posaconazole;", 
                "fluconazole;", 
                "itraconazole."
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Cephalosporins", 
                "Antibiotics, Antitubercular", 
                "Antifungal Agents", 
                "Clotrimazole", 
                "Miconazole", 
                "Itraconazole", 
                "Posaconazole", 
                "Trimethoprim-Sulfamethoxazole Combination"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Adult patients", 
            "Infective events", 
            "Antibiotic", 
            "Antifungal", 
            "Myelodysplastic syndrome"
        ], 
        "lastchanged_date": "March 20, 2014", 
        "link": {
            "url": "http://www.gimema.org/"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Daniela Pietrasanta"
                }, 
                "facility": {
                    "address": {
                        "city": "Alessandria", 
                        "country": "Italy"
                    }, 
                    "name": "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo"
                }, 
                "investigator": [
                    {
                        "last_name": "Daniela Pietrasanta, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Lorella De Paoli, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Antonella Poloni"
                }, 
                "facility": {
                    "address": {
                        "city": "Ancona", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera - Nuovo Ospedale 'Torrette'"
                }, 
                "investigator": [
                    {
                        "last_name": "Antonella Poloni, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Benedetta Costantini, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anna Angela Di Tucci"
                }, 
                "facility": {
                    "address": {
                        "city": "Cagliari", 
                        "country": "Italy"
                    }, 
                    "name": "ASL N.8 - Ospedale \"A. Businco\" - Struttura Complessa di Ematologia e CTMO"
                }, 
                "investigator": [
                    {
                        "last_name": "Anna Angela Di Tucci, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Graziella Pilo, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Rosangela Invernizzi"
                }, 
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy"
                    }, 
                    "name": "Med. Int. ed Oncologia Medica IRCCS Policlinico S. Matteo"
                }, 
                "investigator": [
                    {
                        "last_name": "Rosangela Invernizzi, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Federica Quaglia, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Costanza Bosi"
                }, 
                "facility": {
                    "address": {
                        "city": "Piacenza", 
                        "country": "Italy"
                    }, 
                    "name": "Unit\u00e0 Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza"
                }, 
                "investigator": {
                    "last_name": "Costanza Bosi, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pellegrino Musto"
                }, 
                "facility": {
                    "address": {
                        "city": "Rionero in Vulture", 
                        "country": "Italy"
                    }, 
                    "name": "U.O. di Ematologia - Centro Oncologico Basilicata"
                }, 
                "investigator": [
                    {
                        "last_name": "Pellegrino Musto, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Oreste Villani, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Adriano Venditti"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi - Policlinico di Tor Vergata"
                }, 
                "investigator": [
                    {
                        "last_name": "Adriano Venditti, dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Luca Maurillo, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Livio Pagano, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 Cattolica del Sacro Cuore - Policlinico A. Gemelli"
                }, 
                "investigator": [
                    {
                        "last_name": "Livio Pagano, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Maria Teresa Voso, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicola Cascavilla"
                }, 
                "facility": {
                    "address": {
                        "city": "S. G. Rotondo", 
                        "country": "Italy"
                    }, 
                    "name": "Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza"
                }, 
                "investigator": [
                    {
                        "last_name": "Nicola Cascavilla", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Grazia Sanpaolo, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Observational Prospective Multicenter Study to Evaluate the Infective Risk in Myelodysplastic Syndrome Patients: Antimicrobial Prophylaxis and Granulocyte Growth Factors.", 
        "overall_contact": {
            "email": "p.fazi@gimema.it", 
            "last_name": "Paola Fazi, Dr."
        }, 
        "overall_contact_backup": {
            "email": "e.crea@gimema.it", 
            "last_name": "Enrico Crea"
        }, 
        "overall_official": {
            "affiliation": "Universit\u00e0 Cattolica del Sacro Cuore - Policlinico A. Gemelli - Roma", 
            "last_name": "Livio Pagano, Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Infectious events are fungal and antibiotic events", 
            "measure": "Number of infectious events in myelodysplastic syndrome patients", 
            "safety_issue": "Yes", 
            "time_frame": "at 1 year from study entry"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01951430"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of MDS patients with a febrile event treated with antibiotic, antifungal and antiviral therapy", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Level of neutropenia", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients who recover from infection", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients recovered from infection out of the total of patients with documented infection during the observational period", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients who don't develop bacterial infection", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patient who don't develop fungal infection", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patient who don't develop viral infection", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients that needed granulocyte growth factors", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients that needed iron sequestrating therapy caused by iron overload", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Length of the hospitalization", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Weeks of MDS suspension treatment", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients responding to therapy according to the administered treatment", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of MDS patients alive", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Number of patients without MDS progression", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Need for hospitalization", 
                "safety_issue": "No", 
                "time_frame": "at 1 year from study entry"
            }, 
            {
                "measure": "Level transfusion dependence", 
                "safety_issue": "No", 
                "time_frame": "At one year from study entry"
            }, 
            {
                "measure": "Level of MDS subtype", 
                "safety_issue": "No", 
                "time_frame": "At one year from study entry"
            }, 
            {
                "measure": "Level of risk of  International Prognostic Scoring System (IPSS)", 
                "safety_issue": "Yes", 
                "time_frame": "At one year from study entry"
            }, 
            {
                "measure": "Level of  International Prognostic Scoring System (IPSS)-revised", 
                "safety_issue": "No", 
                "time_frame": "At one year from study entry"
            }, 
            {
                "measure": "Level of iron overload", 
                "safety_issue": "No", 
                "time_frame": "At one year from study entry."
            }
        ], 
        "source": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}